Opinion & features

Neri Oxman gives "Globes" a glimpse into how her company is channeling her vision into real-world transformations, on the small and large scale.

“Globes” calculates who earns what from the $32 billion acquisition of Wiz by Google and how much the Israel Tax Authority will receive.

People don't call in sick to extend their weekends, and parents of young children don't take more sick leave. So what is the main factor?

Israeli venture capitalist Eden Shochat tells the ‘science fiction’ story and inspired bet behind the Israeli startup that has become Apple’s second biggest-ever acquisition.

As the control battle for the aesthetic medicine company heats up, co-founder and CEO Moshe Mizrahy blasts activist investors and backs the employees.

Aviad Maizels has pulled off the unique trick of selling two companies to Apple but this time with much greater financial success.

To overcome the difficulties of holding Bitcoin in Israel, ZOOZ CEO Jordan Fried recommends buying his company’s stock.

The ambition of executing so many major projects all at once, headed by the Metro, is not matched by the availability of resources.

“Globes” examines the urban development challenges facing small towns that will more than double in size in the coming years.

Or Yehuda-based Elsight is traded in Australia and has seen its share price soar 1,000% thanks to the surge in the drones market.

American-Iranian investor Amir Heshmatpour made his fortune in US biotech companies. He’s now in Israel with NeOnc, developer of a nasally administered brain cancer drug.